176 related articles for article (PubMed ID: 36760024)
21. Associations of Incident Cardiovascular Events With Restless Legs Syndrome and Periodic Leg Movements of Sleep in Older Men, for the Outcomes of Sleep Disorders in Older Men Study (MrOS Sleep Study).
Winkelman JW; Blackwell T; Stone K; Ancoli-Israel S; Redline S
Sleep; 2017 Apr; 40(4):. PubMed ID: 28199705
[TBL] [Abstract][Full Text] [Related]
22. Restless legs syndrome does not affect 3-year mortality in hemodialysis patients.
Stefanidis I; Vainas A; Giannaki CD; Dardiotis E; Spanoulis A; Sounidaki M; Eleftheriadis T; Liakopoulos V; Karatzaferi C; Sakkas GK; Zintzaras E; Hadjigeorgiou GM
Sleep Med; 2015 Sep; 16(9):1131-8. PubMed ID: 26298790
[TBL] [Abstract][Full Text] [Related]
23. Prospective study of restless legs syndrome and total and cardiovascular mortality among women.
Li Y; Li Y; Winkelman JW; Walters AS; Han J; Hu FB; Gao X
Neurology; 2018 Jan; 90(2):e135-e141. PubMed ID: 29247069
[TBL] [Abstract][Full Text] [Related]
24. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group.
Garcia-Borreguero D; Kohnen R; Silber MH; Winkelman JW; Earley CJ; Högl B; Manconi M; Montplaisir J; Inoue Y; Allen RP
Sleep Med; 2013 Jul; 14(7):675-84. PubMed ID: 23859128
[TBL] [Abstract][Full Text] [Related]
25. A prospective study of the cumulative incidence and course of restless legs syndrome in de novo patients with Parkinson's disease during chronic dopaminergic therapy.
Marchesi E; Negrotti A; Angelini M; Goldoni M; Abrignani G; Calzetti S
J Neurol; 2016 Mar; 263(3):441-7. PubMed ID: 26566909
[TBL] [Abstract][Full Text] [Related]
26. Efficacy and safety of dopamine agonists in restless legs syndrome.
Hornyak M; Trenkwalder C; Kohnen R; Scholz H
Sleep Med; 2012 Mar; 13(3):228-36. PubMed ID: 22281001
[TBL] [Abstract][Full Text] [Related]
27. Restless legs syndrome in Parkinson's disease: relationship with quality of life and medication.
Minar M; Kosutzka Z; Danterova K; Gmitterova K; Straka I; Kusnirova A; Tosecka R; Juricek R; Kloc M; Wyman-Chick KA; Valkovic P
Bratisl Lek Listy; 2022; 123(1):55-60. PubMed ID: 34967659
[TBL] [Abstract][Full Text] [Related]
28. How effective are treatment guidelines for augmented RLS?
Yeung Laiwah J; Winkelman JW
Sleep; 2022 Jul; 45(7):. PubMed ID: 35532181
[TBL] [Abstract][Full Text] [Related]
29. Treating Restless Legs Syndrome Was Associated With Low Risk of Cardiovascular Disease: A Cohort Study With 3.4 Years of Follow-Up.
Gao X; Ba DM; Bagai K; Liu G; Ma C; Walters AS
J Am Heart Assoc; 2021 Feb; 10(4):e018674. PubMed ID: 33550813
[TBL] [Abstract][Full Text] [Related]
30. Treatment initiation and utilization patterns of pharmacotherapies for early-onset idiopathic restless legs syndrome.
Costales B; Vouri SM; Brown JD; Setlow B; Goodin AJ
Sleep Med; 2022 Aug; 96():70-78. PubMed ID: 35605349
[TBL] [Abstract][Full Text] [Related]
31. Restless legs syndrome: pathophysiology and modern management.
Nagandla K; De S
Postgrad Med J; 2013 Jul; 89(1053):402-10. PubMed ID: 23524988
[TBL] [Abstract][Full Text] [Related]
32. Targeted Pressure on Abductor Hallucis and Flexor Hallucis Brevis Muscles to Manage Moderate to Severe Primary Restless Legs Syndrome.
Kuhn PJ; Olson DJ; Sullivan JP
J Am Osteopath Assoc; 2016 Jul; 116(7):440-50. PubMed ID: 27367949
[TBL] [Abstract][Full Text] [Related]
33. Restless Legs Syndrome Following Lung Transplantation: Prevalence and Relationship With Tacrolimus Exposure.
Menninga NJ; Rohde KA; Schlei ZW; Katers KM; Weber AK; Brokhof MM; Hawes DS; Radford KL; Francois ML; Cornwell RD; Benca R; Hayney MS; Dopp JM
Prog Transplant; 2016 Jun; 26(2):149-56. PubMed ID: 27207403
[TBL] [Abstract][Full Text] [Related]
34. Obesity and restless legs syndrome in men and women.
Gao X; Schwarzschild MA; Wang H; Ascherio A
Neurology; 2009 Apr; 72(14):1255-61. PubMed ID: 19349606
[TBL] [Abstract][Full Text] [Related]
35. The seasonal pattern of restless legs syndrome in a sample from the Korean Health Insurance Review and Assessment Service national database.
Oh SM; Son KL; Choi SJ; Lee MH; Yoon SY; Lee YJ
J Clin Sleep Med; 2021 May; 17(5):1051-1056. PubMed ID: 33570488
[TBL] [Abstract][Full Text] [Related]
36. Treating Severe Refractory and Augmented Restless Legs Syndrome.
Winkelman JW
Chest; 2022 Sep; 162(3):693-700. PubMed ID: 35609673
[TBL] [Abstract][Full Text] [Related]
37. Restless legs syndrome: clinical experience with long-term treatment.
Clavadetscher SC; Gugger M; Bassetti CL
Sleep Med; 2004 Sep; 5(5):495-500. PubMed ID: 15341896
[TBL] [Abstract][Full Text] [Related]
38. Randomized, double-blind, placebo-controlled, short-term trial of ropinirole in restless legs syndrome.
Bliwise DL; Freeman A; Ingram CD; Rye DB; Chakravorty S; Watts RL
Sleep Med; 2005 Mar; 6(2):141-7. PubMed ID: 15716217
[TBL] [Abstract][Full Text] [Related]
39. Restless legs syndrome in the older adult: diagnosis and management.
Milligan SA; Chesson AL
Drugs Aging; 2002; 19(10):741-51. PubMed ID: 12390051
[TBL] [Abstract][Full Text] [Related]
40. Long-term open-label study of pramipexole in patients with primary restless legs syndrome.
Inoue Y; Kuroda K; Hirata K; Uchimura N; Kagimura T; Shimizu T
J Neurol Sci; 2010 Jul; 294(1-2):62-6. PubMed ID: 20451927
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
